ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
93 hedge funds and large institutions have $263M invested in Achillion Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 37 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
-9
Holders Change %
-8.82%
% of All Funds
2.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
28
Reduced
37
Closed
26
Calls
$42.6M
Puts
$6.38M
Net Calls
+$36.2M
Net Calls Change
-$12.6M
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$29.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$6.54M |
| 3 |
BC
Broadfin Capital
New York
|
+$3.32M |
| 4 |
VAM
Visium Asset Management
New York
|
+$3.06M |
| 5 |
DAM
Doheny Asset Management
Los Angeles,
California
|
+$3.02M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.1M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$7.28M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$6.83M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$5.11M |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
-$3.48M |
